Cell Culture Market worth $24,574 million by 2018, According to a New Study on ASDReports

Tuesday 2 September 2014, Amsterdam

The “Cell Culture Market by Equipment (Bioreactor, Incubator, Centrifuge), by Reagent (Media, Sera, Growth Factors, Serum Free Media), by Application (Cancer Research, Gene Therapy, Drug Development, Vaccine Production, Toxicity Testing) - Global Forecast to 2018” report, now available on ASDReports, provides a detailed overview of the major drivers, restraints, challenges, opportunities, current market trends, and strategies impacting the global cell culture market along with the estimates and forecasts of the revenue and market share analysis.

The global cell culture market was valued at an estimated $14,772 million in 2013. This market is expected to grow at a CAGR of 10.71% between 2013 and 2018, to reach $24,574 million in 2018.

The cell culture market is segmented on the basis of cell culture equipment and cell culture media, sera, and reagents. Each of these two market segments is further divided into multiple product segments and subsegments. The cell culture equipment market consists of five segments, namely, bio-safety cabinets, consumables, lab equipment, sterilization equipment, and storage equipment. Of these, the lab equipment product segment had the largest share of the cell culture equipment market in 2013, whereas the consumables product segment is expected to grow at the highest CAGR between 2013 and 2018. The subsegments of the lab equipment segment are cell counters, centrifuges fermentors & bioreactors, and incubators. The subsegments of the storage equipment segments are cryogenic storage and refrigerators and freezers.

The cell culture media, sera, and reagents market consists of six segments, namely, contamination detection kits, cryoprotective agents, lab reagents, media, serum, and other reagents. Of these, the serum product segment had the largest share of the cell culture media, sera, and reagents market in 2013, whereas the media product segment is expected to grow at the highest CAGR between 2013 and 2018. The subsegments of the lab reagents segment are balanced salt solutions, buffers and chemicals, cell dissociation reagents, and supplements and growth factors. The subsegments of the media segment are basal media, reduced serum media, and serum-free media.

The application segments included in this report are biopharmaceutical production, cancer research, drug screening and development, gene therapy, tissue culture and engineering, toxicity testing, vaccine production, and other applications. The biopharmaceutical production application segment had the largest share of the cell culture equipment market in 2013, whereas the vaccine production application segment is expected to grow at the highest CAGR between 2013 and 2018. The geographic segments included in this report are North America, Europe, Asia-Pacific, and Rest of the World.

Biopharmaceuticals are pharmaceutical products isolated from living systems like cells. As such, cell culture is the most widely used technique for biopharmaceutical production. Increasing demand for biopharmaceuticals will be the most important growth driver for the cell culture market. Furthermore, strong product pipelines for vaccine and antibodies, increasing healthcare expenditure, and increasing adoption of single-use technologies will aid the growth of this market.

The major players in the cell culture market include Becton, Dickinson and Company (U.S.), Corning (U.S.), Eppendorf (Germany), General Electric (U.S.), Lonza (Switzerland), Merck (Germany), Promocell (Germany), Sartorius (Germany), Sigma-Aldrich Corporation (U.S.), and Thermo Fisher Scientific (U.S.).